Abstract
A convenient and straightforward synthesis of structurally diverse 2-methyl-N-[(3-phenylamino)oxetan-3-yl]-2-propanesulfinamide derivatives from 3-oxetan-3-tert-butylsulfinimine and substituted aromatic amines in methanol at 60 °C temperature is described. The corresponding diaminooxetane derivatives are obtained in good to excellent yield under optimized reaction conditions. The method presented herein was found to be advantageous for diaminooxetane derivatives as emerging building block for future drug discovery. The title diaminooxetanes should be considered as bioisosteric to isopropylidenediamines and urea derivatives rather than to gem-dimethyl and carbonyl groups, respectively.
Graphical abstract
Similar content being viewed by others
References
Berthelot M, Besseau F, Laurence C (1998) The hydrogen-bond basicity pKHB scale of peroxides and ethers. Eur J Org Chem. doi:10.1002/(SICI)1099-0690(199805)1998:5<925:AID-EJOC925>3.0.CO;2-F
Besseau F, Lucon M, Laurence C, Berthelot M (1998) Hydrogen-bond basicity pKHB scale of aldehydes and ketones. J Chem Soc Perkin Trans 2:101–108. doi:10.1039/A704427E
Bull JA, Croft RA, Davis OA, Doran R, Morgan KF (2016) Oxetanes: recent advances in synthesis, reactivity and medicinal Chemistry. Chem Rev 116(19):12150–12233. doi:10.1021/acs.chemrev.6b00274
Burkhard JA, Wultschik G, Plancher JM, Roger-Evans M, Carreira EM (2013) Synthesis and stability of oxetane analogs of thalidomide and lenalidomide. Org Lett 15(17):4312–4315. doi:10.1021/ol401705a
Cavalli A, Poluzzi E, De Ponti F, Racanatini M (2002) Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J Med Chem 45(18):3844–3853. doi:10.1021/jm0208875
Cogan DA, Liu G, Ellman J (1999) The asymmetric synthesis of alpha, alpha-dibranched amines by the trimethylaluminum mediated 1,2-addition of organolithiums to tert-butanesulfinyl ketimines. J Am Chem Soc 121:268–269. doi:10.1021/ja983217q
Fischer H, Kansy M, Bur D (2000) CAFA: a Novel tool for the calculation of amphiphilic properties of charged drug molecules. Chimia 54(11):640–645
Gholap SS (2016) Pyrrole: an emerging scaffold for construction of valuable therapeutic agents. Eur J Med Chem 110:13–31. doi:10.1016/j.ejmech.2015.12.017
Gholap SS, Bandgar BP, Chavan HV, Dhakane VD, Deshmukh UP (2014) An efficient and green method for the synthesis of [1,3]oxazine derivatives catalyzed by thiamine hydrochloride (VB1) in wateri C. R Chim 17(6):431–436. doi:10.1016/j.crci.2013.06.002
Gholap SS, Dhakane VD, Gholap Sandip S (2012) Solid-supported dichloro[1,3,5]-triazine: a versatile synthetic auxiliary for direct synthesis of N-sulfonylamines from sulphonic acid and amine. Jordan J Chem 7(3):279–285
Gholap SS, Gunjal N (2017) 2,4,6-Trichloro-1,3,5-triazine (TCT) mediated one pot direct synthesis of N-benzoylthioureas from carboxylic acids. Arabian J Chem 10:S2750–S2753. doi:10.1016/j.arabjc.2013.10.021
Gholap SS, Deshmukh UP (2013) Synthesis and in vitro antimicrobial screening of 3-cinnamoyl coumarin and 3-[3-(1H-indol-2-yl)-3-aryl-propanoyl]-2H-chromen-2-ones. Iran J Catal 3:171–176. http://ijc.iaush.ac.ir/article_4966.html. Accessed 29 Sept 2013
Gholap SS, Gunjal N (2016) Thiamine hydrochloride (Vit-B1): An optimized green alternative for the synthesis of polyhydroquinoline derivatives. Iran J Catal 8:6(2):147–152. http://ijc.iaush.ac.ir/article_13482.html. Accessed 10 Dec 2015
Hamzik PJ, Brubaker JD (2010) Reactions of oxetan-3-tert-butylsulfinimine for the preparation of substituted 3-aminooxetanes. Org Lett 12(5):1116–1119. doi:10.1021/ol100119e
Hashino H, Shimizu N, Shimida N, Takita T, Takeuchi T, Hoshino H (1987) Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds. Antibiot 40:1077–1078
Holan G (1971) Rational design of degradable insecticides. Nature (London) 232:644–647
Huang JM, Yokoyama R, Yang CS, Fukuyama Y (2000) Merrilactone A, a novel neurotrophic sesquiterpene dilactone from Illicium merrillianum. Tetrahedron Lett 41(32):6111–6114
Li C, Lee D, Graf TN, Phifer SS, Nakanishi Y, Burgess JP, Riswan R, Setyowati FM, Sarebi AM, Kroll DD, Kingborn AD, Wani MC, Oberlies NH (2005) A hexacyclic ent-trachylobane diterpenoid possessing an oxetane ring from Mitrephora glabra. Org Lett 7:5709–5712. doi:10.1021/ol052498l
Liu G, Cogan DA, Owens TD, Tang TP, Ellman J (1999) Synthesis of enantiomerically pure N-tert-butanesulfinyl imines (tert-butanesulfinimines) by the direct condensation of tert-butanesulfinamide with aldehydes and ketones. J Org Chem 64:1278–1284. doi:10.1021/jo982059i
Loh J, Carrison RW, York WS, Stacey G (2002) Bradyoxetin, a unique chemical signal involved in symbiotic gene regulation. Proc Natl Acad Sci USA 99:14446–14451. doi:10.1073/pnas.222336799
MacLaughlin M, Yazaki R, Fessard TC, Carreira EM (2014) Oxetanyl peptides: novel peptidomimetic modules for medicinal chemistry. Org Lett 16:4070–4073. doi:10.1021/ol501590n
Malapit CA, Howell AR (2015) Recent applications of oxetanes in the synthesis of heterocyclic compounds. J Org Chem 80(17):8489–8495. doi:10.1021/acs.joc.5b01255
Mayer W, Ciba-Geigy AG (1992) EP 92-810027
Norbeck DW, Kramer JB (1988) Nucleoside mimetics: their chemistry and biological properties. J Am Chem Soc 110:7217–7218
Omura S, Murata M, Imamura N, Iwai Y, Tanaka H, Furusaki A, Matsumoto T (1984) Oxetin, a new antimetabolite from an actinomycete. Fermentation, isolation, structure and biological activity. J Antibiot (Tokyo) 37:1324–1342
Seki JL, Shimida N, Takahashi K, Takita T, Takeuchi T, Hoshino H (1989) Inhibition of infectivity of HIV by a novel nucleoside, oxetanocin, and related compounds. Antimicrob Agents Chemother 33:773–775. doi:10.1128/AAC.33.5.773
Shimada N, Hasegawa S, Harada T, Tomisawa T, Fujji A, Takita T (1986) Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G. J Antibiot 39:1623–1625
Soloway SB, Vogel P, Aubin le Drian CH, Powell JE (1986) DuPont de Nemours, E.I. and Co, US 86-916334
Stephan AF, Karki K, McDonald WS, Dorff PH, Dutra JK, DiRico KJ, Won A, Subramanyam C, Efremov IV, O’Donnell CJ, Nolan CE, Becker SL, Pustilnik LR, Sneed B, Sun H, Lu Y, Robshaw AE, Riddell D, O’Sullivan TJ, Sibley E, Capetta S, Atchison K, Hallgren AJ, Miller E, Wood A, Obach RS (2011) Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors. J Med Chem 54:7772–7783. doi:10.1021/jm200893p
Wani MC, Taylor HL, Wall ME, Coggon P, Mcphail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327
Wuitschik G, Carreira EM, Roger- Envans M, Muller K (2008) In: Gadamasetti K, Braish T (eds) Oxetan-3-one: chemistry and synthesis in process chemistry in the Pharmaceutical Industry. Boca raton, CRC, pp 217–229
Wuitschik G, Carreira EM, Wanger B, Fischer H, Parrilla I, Schuler F, Envans MR, Muller K (2010) J Med Chem 53:3227–3246. doi:10.1021/jm9018788
Wuitschik G, Rogers-Envans M, Muller K, Bucki A, Bernasconi M, Godel T, Fischer H, Wanger B, Parrilla I, Schuler F, Schneider J, Alker A, Schweinzer WB, Carreira EM (2006a) Spirocyclic oxetane: synthesis and properties. Angew Chem Int Ed 47:4512–4515. doi:10.1002/anie.200800450
Wuitschik G, Rogers-Envans M, Muller K, Fischer H, Wanger B, Schuler F, Polonchuk L, Carreira EM (2006b) Oxetane as promising modules in drug discovery. Angew Chem Int Ed 45:7736–7739. doi:10.1002/anie.200602343
Wuitschik G, PhD thesis, ETH, Zurich (2008) doi:10.3929/etz-a-005697432
Acknowledgements
Authors are thankful to Principal, P. V. P. College, Pravaranagar for providing necessary laboratory facilities and Dr. C. H. Gill for constant encouragement.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ugale, S.R., Gholap, S.S. An efficient synthesis of structurally diverse 2-methyl-N-[(3-phenylamino)oxetan-3-yl]-2-propanesulfinamide derivatives under catalyst free conditions. Chem. Pap. 71, 2435–2443 (2017). https://doi.org/10.1007/s11696-017-0237-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-017-0237-1